Altogether, the presence of STIP1 autoantibodies may disrupt the STIP1-to-PrPC engagement and the STIP1’s role as a co-chaperone when it associates with HSP70, possibly increasing an individual’s risk of the development of Parkinson’s disease. This evidence concerns the gene STIP1 and Parkinson disease.